Lisbet Van Landuyt
Overview
Explore the profile of Lisbet Van Landuyt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
465
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wouters K, Mateizel I, Segers I, Van de Velde H, Van Landuyt L, De Vos A, et al.
Hum Reprod
. 2024 Sep;
39(10):2233-2239.
PMID: 39241807
Study Question: Is there a difference in clinical pregnancy rates (CPRs) in good prognosis patients after single embryo transfer (SET) on Day 5, in case of stable culture at 36.6°C...
2.
Adriaenssens T, Van Vaerenbergh I, Van Landuyt L, Verheyen G, De Brucker M, Camus M, et al.
PLoS One
. 2024 Jan;
19(1):e0297040.
PMID: 38295095
Research Question: Can a strategy for scoring oocyte quality, based on cumulus cell (CC) gene expression, prioritize oocytes with the highest implantation potential, while limiting the number of embryos to...
3.
Racca A, Santos-Ribeiro S, Drakopoulos P, De Coppel J, Van Landuyt L, Tournaye H, et al.
Reprod Biol Endocrinol
. 2023 Jul;
21(1):62.
PMID: 37420186
Research Question: Does a frozen-embryo transfer in an artificially-prepared endometrium (FET-HRT) cycle yield similar clinical pregnancy rate with 7 days of oestrogen priming compared to 14 days? Design: This is...
4.
Sterckx J, Wouters K, Mateizel I, Segers I, De Vos A, Van Landuyt L, et al.
Hum Reprod
. 2023 Jun;
38(8):1529-1537.
PMID: 37295967
Study Question: What have we learnt after 10 years of electronic witnessing? Summary Answer: When applied correctly, an electronic witnessing system can replace manual witnessing in the medically assisted reproduction...
5.
Mackens S, Pais F, Drakopoulos P, Amghizar S, Roelens C, Van Landuyt L, et al.
Reprod Biomed Online
. 2023 Apr;
46(6):939-945.
PMID: 37012101
Research Question: Does additional supplementation with oral dydrogesterone improve reproductive outcomes in patients with low serum progesterone concentrations on the day of frozen embryo transfer (FET) after artificial (HRT) endometrial...
6.
Belva F, Blockeel C, Keymolen K, Buysse A, Bonduelle M, Verheyen G, et al.
Fertil Steril
. 2023 Feb;
119(6):932-941.
PMID: 36774979
Objective: To assess health outcomes, including growth up to 2 years of age, in children born after embryo vitrification in comparison with children born after fresh embryo transfer. Design: A...
7.
Roelens C, Racca A, Mackens S, Van Landuyt L, Buelinckx L, Gucciardo L, et al.
Reprod Biomed Online
. 2022 Mar;
44(5):915-922.
PMID: 35282993
Research Question: What is the association between the development of pre-eclampsia and endometrial preparation prior to vitrified-warmed embryo transfer (frozen embryo transfer, FET)? Design: A retrospective cohort study at a...
8.
Van Vaerenbergh I, Adriaenssens T, Coucke W, Van Landuyt L, Verheyen G, De Brucker M, et al.
Reprod Biol Endocrinol
. 2021 Feb;
19(1):26.
PMID: 33608027
Background: Non-invasive oocyte quality scoring, based on cumulus gene expression analysis, in combination with morphology scoring, can increase the clinical pregnancy (CPR) and live birth rates (LBR) in Day 3...
9.
De Vos A, Van Landuyt L, De Rycke M, Verdyck P, Verheyen G, Buysse A, et al.
Hum Reprod
. 2020 Oct;
35(11):2488-2496.
PMID: 33047114
Study Question: Does double vitrification and warming of human blastocysts having undergone biopsy once or twice have an impact on the clinical outcome? Summary Answer: The clinical pregnancy rate obtained...
10.
Santos-Ribeiro S, Mackens S, Popovic-Todorovic B, Racca A, Polyzos N, Van Landuyt L, et al.
Hum Reprod
. 2020 Sep;
35(12):2808-2818.
PMID: 32964939
Study Question: Does the freeze-all strategy in high-responders increase pregnancy rates and improve safety outcomes when compared with GnRH agonist triggering followed by low-dose hCG intensified luteal support with a...